ACHE and Alzheimer disease: As a result, acetylcholinesterase inhibitors targeting AChE are mainly used to treat AD in the clinic, according to the “cholinergic hypothesis.” Four of the five anti-AD drugs approved by the FDA include AChE inhibitors (namely tacrine, donepezil, galanthamine, and rivastigmine, Figure 1) [13,14].